115 related articles for article (PubMed ID: 1936478)
1. Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD.
Noury J; Nandeuil A
Diabete Metab; 1991 May; 17(1 Pt 2):209-12. PubMed ID: 1936478
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic effects of gliclazide in diabetes type II patients. Study with indirect calorimetry].
Golay A; Broquet C; Chabot V; Studer S; Felber JP
Schweiz Med Wochenschr; 1984 Feb; 114(8):261-4. PubMed ID: 6369531
[TBL] [Abstract][Full Text] [Related]
3. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
Ponssen HH; Elte JW; Lehert P; Schouten JP; Bets D
Clin Ther; 2000 Jun; 22(6):709-18. PubMed ID: 10929918
[TBL] [Abstract][Full Text] [Related]
4. Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.
Matthews DR; Charbonnel BH; Hanefeld M; Brunetti P; Schernthaner G
Diabetes Metab Res Rev; 2005; 21(2):167-74. PubMed ID: 15386821
[TBL] [Abstract][Full Text] [Related]
5. [Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data].
Galeone F; Fiore G; Arcangeli A; Mannucci E
Minerva Endocrinol; 1998 Sep; 23(3):71-5. PubMed ID: 10063324
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin assay: an important therapeutic tool in management of freshly diagnosed type 2 diabetes mellitus.
Saxena T; Maheshwari S; Goyal RK
J Assoc Physicians India; 2000 Aug; 48(8):815-7. PubMed ID: 11273476
[TBL] [Abstract][Full Text] [Related]
7. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
8. The effect of short-term glycemic regulation with gliclazide and metformin on postprandial lipemia.
Emral R; Köseoğlulari O; Tonyukuk V; Uysal AR; Kamel N; Corapçioğlu D
Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):80-4. PubMed ID: 15772898
[TBL] [Abstract][Full Text] [Related]
9. A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial.
Charbonnel BH; Matthews DR; Schernthaner G; Hanefeld M; Brunetti P;
Diabet Med; 2005 Apr; 22(4):399-405. PubMed ID: 15787663
[TBL] [Abstract][Full Text] [Related]
10. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
Habib SS; Aslam M; Naveed AK; Razi MS
Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
[TBL] [Abstract][Full Text] [Related]
11. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects.
Formoso G; De Filippis EA; Michetti N; Di Fulvio P; Pandolfi A; Bucciarelli T; Ciabattoni G; Nicolucci A; Davì G; Consoli A
Diabetes Metab Res Rev; 2008; 24(3):231-7. PubMed ID: 17966969
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
13. A comparison of treatment with metformin and gliclazide in patients with non-insulin-dependent diabetes.
McAlpine LG; McAlpine CH; Waclawski ER; Storer AM; Kay JW; Frier BM
Eur J Clin Pharmacol; 1988; 34(2):129-32. PubMed ID: 3289948
[TBL] [Abstract][Full Text] [Related]
14. Hypolipidemic effects of metformin in hyperprebetalipoproteinemia.
Fedele D; Tiengo A; Nosadini R; Marchiori E; Briani G; Garotti MC; Muggeo M
Diabete Metab; 1976 Sep; 2(3):127-33. PubMed ID: 188698
[TBL] [Abstract][Full Text] [Related]
15. Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats.
Louro TM; Matafome PN; Nunes EC; da Cunha FX; Seiça RM
Eur J Pharmacol; 2011 Feb; 653(1-3):89-94. PubMed ID: 21167150
[TBL] [Abstract][Full Text] [Related]
16. Genetic cause of hyperglycaemia and response to treatment in diabetes.
Pearson ER; Starkey BJ; Powell RJ; Gribble FM; Clark PM; Hattersley AT
Lancet; 2003 Oct; 362(9392):1275-81. PubMed ID: 14575972
[TBL] [Abstract][Full Text] [Related]
17. A comparison of phenformin and metformin in the treatment of maturity onset diabetes.
Cairns SA; Shalet S; Marshall AJ; Hartog M
Diabete Metab; 1977 Sep; 3(3):183-8. PubMed ID: 913750
[TBL] [Abstract][Full Text] [Related]
18. The effect of sulphonylurea therapy on skeletal muscle glycogen synthase activity and insulin secretion in newly presenting type 2 (non-insulin-dependent) diabetic patients.
Johnson AB; Argyraki M; Thow JC; Jones IR; Broughton D; Miller M; Taylor R
Diabet Med; 1991 Apr; 8(3):243-53. PubMed ID: 1828740
[TBL] [Abstract][Full Text] [Related]
19. A simple acute in vivo comparative test for sensitivity to insulin in the mouse.
Williams CA; Shih MF; Taberner PV
Horm Metab Res; 1999 Oct; 31(10):580-2. PubMed ID: 10596969
[TBL] [Abstract][Full Text] [Related]
20. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.
Collier A; Watson HH; Patrick AW; Ludlam CA; Clarke BF
Diabete Metab; 1989; 15(6):420-5. PubMed ID: 2534084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]